Protocol summary

Study aim
To evaluate the effect of levothyroxine on serum lipid profile in adults with subclinical hypothyroidism. LDL-C, total cholesterol, triglycerides and HDL-C will be assessed at baseline and 12 weeks.
Design
Prospective, single-arm, interventional study conducted at the Department of Medicine, CMH Hyderabad. Participants will undergo baseline assessment before initiation of levothyroxine therapy and will be followed for 12 weeks with predefined clinical and laboratory assessments.
Settings and conduct
Following approval from the Institutional Ethical Review Committee of CMH Hyderabad and prospective registration of the study, eligible participants will be recruited from the Department of Medicine. Participants will undergo baseline clinical assessment and laboratory investigations before initiation of treatment and will subsequently be assessed at predefined follow-up visits. Confidentiality and secure handling of participant data will be maintained according to institutional requirements.
Participants/Inclusion and exclusion criteria
Adults aged 18–65 years with biochemically confirmed subclinical hypothyroidism who are eligible for levothyroxine. Exclude overt thyroid dysfunction, previous thyroid replacement therapy, pregnancy/lactation, and inability or unwillingness to comply with treatment and follow-up.
Intervention groups
All enrolled patients received the same levothyroxine regimen of 1.6 mcg/kg/day.
Main outcome variables
Primary outcome: change in serum LDL-C, total cholesterol, triglycerides and HDL-C from baseline to 12 weeks. Secondary outcomes: change in serum TSH and time to biochemical euthyroidism.

General information

Reason for update
Acronym
LIPOTHY
IRCT registration information
IRCT registration number: IRCT20260622069921N2
Registration date: 2026-09-24, 1405/07/02
Registration timing: prospective

Last update: 2026-09-24, 1405/07/02
Update count: 0
Registration date
2026-09-24, 1405/07/02
Registrant information
Name
Muhammad Ali Aslam
Name of organization / entity
Armed forces post graduate medical institute Rawalpindi
Country
Pakistan
Phone
+92 341 0441717
Email address
aliaslam187@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2026-10-05, 1405/07/13
Expected recruitment end date
2026-10-20, 1405/07/28
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Effect of Levothyroxine Replacement on Serum Lipid Profile in Adults With Subclinical Hypothyroidism: A Prospective Interventional Study
Public title
Changes in Serum Lipid Profile After Levothyroxine Treatment in Adults With Subclinical Hypothyroidism
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Adult aged 18 - 65 years. Biochemically confirmed subclinical hypothyroidism, defined as elevated serum TSH with free T4 within the laboratory reference range. Patients who are willing to initiate levothyroxine therapy according to the study protocol. Patients willing to attend the scheduled follow-up visits for 12 weeks.
Exclusion criteria:
Previously diagnosed overt hypothyroidism or hyperthyroidism. Previous or current thyroid hormone replacement therapy. Pregnancy or lactation. Patients who decline or withdraw informed consent. Patients unable or unwilling to comply with the treatment and follow-up
Age
From 18 years old to 65 years old
Gender
Both
Phase
N/A
Groups that have been masked
No information
Sample size
Target sample size: 112
More than 1 sample in each individual
Number of samples in each individual: 2
Venous blood sample collected at baseline and at 12 weeks for measurement of serum TSH and lipid profile (total cholesterol, LDL-C, HDL-C and triglycerides).
Randomization (investigator's opinion)
N/A
Randomization description
Blinding (investigator's opinion)
Not blinded
Blinding description
Placebo
Not used
Assignment
Single
Other design features
Prospective single-arm interventional before-and-after study. Participants will be assessed at baseline before initiation of levothyroxine therapy and followed prospectively for 12 weeks, with predefined clinical and laboratory assessments at specified follow-up visits.

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
The Ethical Committee/Institutional Review Board of CMH Hyderabad
Street address
CMH road, Saddar, Cantonment, CMH Hyderabad.
City
Hyderabad
Postal code
71110
Approval date
2026-01-01, 1404/10/11
Ethics committee reference number
No/11200/Estb

Health conditions studied

1

Description of health condition studied
Subclinical hypothyroidism is a biochemical condition characterized by an elevated serum thyroid-stimulating hormone concentration with free thyroxine concentration within the reference range. It may be associated with metabolic abnormalities, including alterations in serum lipid concentrations. This study will prospectively evaluate changes in lipid parameters following levothyroxine replacement therapy.
ICD-10 code
E03.9
ICD-10 code description
Hypothyroidism, unspecified

Primary outcomes

1

Description
Lipid Profile
Timepoint
Change in serum lipid levels at baseline (before initiation of levothyroxine therapy) and 12 weeks after initiation of therapy
Method of measurement
Fasting venous blood samples will be collected at baseline and at 12 weeks. Serum Lipid levels will be measured using the institution’s standard laboratory method.

Secondary outcomes

1

Description
Change in serum TSH concentration from baseline to 12 weeks.
Timepoint
Baseline and 12 weeks after initiation of levothyroxine therapy.
Method of measurement
Fasting venous blood samples will be collected at baseline and at 12 weeks. Serum TSH levels will be measured using the institution’s standard laboratory method.

2

Description
Time required to achieve biochemical euthyroidism, defined according to the predefined serum TSH target in the study protocol.
Timepoint
Baseline and 12 weeks after initiation of levothyroxine therapy.
Method of measurement
Fasting venous blood samples will be collected at baseline and at 12 weeks. Serum TSH levels will be measured using the institution’s standard laboratory method.

Intervention groups

1

Description
Levothyroxine sodium will be administered orally at an initial dose of 1.6 μg/kg/day according to the predefined study protocol. The medication will be taken once daily in the morning on an empty stomach with water. Dose adjustments, if required, will be made according to predefined TSH targets and documented during follow-up.
Category
Treatment - Drugs

Recruitment centers

1

Recruitment center
Name of recruitment center
CMH Hyderabad, Hyderabad Cantonment
Full name of responsible person
Dr. Asad Mahmood
Street address
CMH Road, Saddar, Cantonment, CMH Hyderabad
City
Hyderabad
Postal code
71110
Phone
+92 341 0441717
Email
aliaslam187@gmail.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
CMH Hyderabad
Full name of responsible person
Dr. Asad Mahmood
Street address
CMH Road, Saddar, Cantonment, CMH Hyderabad
City
Hyderabad
Postal code
71110
Phone
+92 341 0441717
Email
aliaslam187@gmail.com
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
CMH Hyderabad
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Other

Person responsible for general inquiries

Contact
Name of organization / entity
CMH Hyderabad
Full name of responsible person
Dr. Asad Mahmood
Position
Consultant
Latest degree
Specialist
Other areas of specialty/work
Internal Medicine
Street address
CMH Road, Saddar, Cantonment, CMH Hyderabad
City
Hyderabad
Province
Sindh
Postal code
71110
Phone
+92 316 4757170
Email
asad1620@gmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
CMH Hyderabad
Full name of responsible person
Dania Mudassar
Position
General Dentist
Latest degree
Bachelor
Other areas of specialty/work
Dentistry
Street address
CMH Road, Saddar, Cantonment
City
Hyderabad
Province
Sindh
Postal code
71110
Phone
+92 341 5072055
Email
dania.mudassar@outlook.com

Person responsible for updating data

Contact
Name of organization / entity
CMH Hyderabad
Full name of responsible person
Dania Mudassar
Position
General Dentist
Latest degree
Bachelor
Other areas of specialty/work
Dentistry
Street address
CMH Road, Saddar, Cantonment
City
Hyderabad
Province
Sindh
Postal code
71110
Phone
+92 341 5072055
Email
dania.mudassar@outlook.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
No - There is not a plan to make this available
Justification/reason for indecision/not sharing IPD
Limitations in participant consent, data sharing policy of institute and confidentiality of study participants.
Study Protocol
No - There is not a plan to make this available
Statistical Analysis Plan
No - There is not a plan to make this available
Informed Consent Form
No - There is not a plan to make this available
Clinical Study Report
No - There is not a plan to make this available
Analytic Code
No - There is not a plan to make this available
Data Dictionary
No - There is not a plan to make this available
Loading...